Qualaquin, the only quinine that FDA allows on the market, is too expensive

May 2007

Patients are complaining that Qualaquin, the only quinine that FDA allows on the market, is too expensive.

It's a complicated tangle. Quinine had never been approved by the FDA. It was on the market before approval was required.

When FDA finally considered studies and approved Qualaquin last year, they decided it was safe ONLY for malaria...and not for leg cramps. And they took the non-approved quinines off the market.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote